These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma. Vaarwerk B; Breunis WB; Haveman LM; de Keizer B; Jehanno N; Borgwardt L; van Rijn RR; van den Berg H; Cohen JF; van Dalen EC; Merks JH Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012325. PubMed ID: 34753195 [TBL] [Abstract][Full Text] [Related]
3. The impact of Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508 [TBL] [Abstract][Full Text] [Related]
4. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma? Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285 [TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
6. Additional Benefit of F-18 FDG PET/CT in the staging and follow-up of pediatric rhabdomyosarcoma. Ricard F; Cimarelli S; Deshayes E; Mognetti T; Thiesse P; Giammarile F Clin Nucl Med; 2011 Aug; 36(8):672-7. PubMed ID: 21716019 [TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. Völker T; Denecke T; Steffen I; Misch D; Schönberger S; Plotkin M; Ruf J; Furth C; Stöver B; Hautzel H; Henze G; Amthauer H J Clin Oncol; 2007 Dec; 25(34):5435-41. PubMed ID: 18048826 [TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT is useful in initial staging, restaging for pediatric rhabdomyosarcoma. Dong Y; Zhang X; Wang S; Chen S; Ma C Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):438-446. PubMed ID: 25996974 [TBL] [Abstract][Full Text] [Related]
9. ¹⁸F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas. Eugene T; Corradini N; Carlier T; Dupas B; Leux C; Bodet-Milin C Nucl Med Commun; 2012 Oct; 33(10):1089-95. PubMed ID: 22929116 [TBL] [Abstract][Full Text] [Related]